Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula

Ankush Gupta; Rajat Datta; Sanya Chhikara; Peeyush K Dhagat; Rajesh Vijayvergiya

doi:10.1016/j.jaccas.2020.07.041

Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula

JACC Case Rep. 2020 Sep 15;2(11):1692-1697. doi: 10.1016/j.jaccas.2020.07.041. eCollection 2020 Sep.

Authors

Ankush Gupta¹, Rajat Datta², Sanya Chhikara¹, Peeyush K Dhagat³, Rajesh Vijayvergiya⁴

Affiliations

¹ Department of Cardiology, Base Hospital Delhi Cantt, New Delhi, India.
² Department of Cardiology, Army Hospital Research and Referral, New Delhi, India.
³ Department of Radiology, Base Hospital Delhi Cantt, New Delhi, India.
⁴ Department of Cardiology, PGIMER Chandigarh, Chandigarh, India.

Abstract

Coronary artery aneurysm (CAA) after drug-eluting stent implantation is rare, with a reported incidence of 0.3% to 6.0%. Most of these aneurysms are asymptomatic. Hemoptysis as a presentation of CAA is very rare. The patient in our case had CAA after zotarolimus-eluting stent implantation and presented with hemoptysis resulting from a leaking coronary-bronchial fistula. (Level of Difficulty: Intermediate.).

Keywords: BMS, bare metal stent(s); CAA, coronary artery aneurysm; CT, computed tomography; DES, drug-eluting stent(s); ECG, electrocardiogram; LA, left atrial; LAD, left anterior descending; LCX, left circumflex; LM, left main (coronary artery); LV, left ventricular; NC, noncompliant; PCI, percutaneous coronary intervention; complication; coronary angiography; percutaneous coronary intervention.

Publication types

Case Reports